1 2 3 4 105 Previous Next

Intel Newsroom

1,562 Posts

Avago Technologies Limited and Intel today announced the signing of a definitive agreement for Intel to acquire LSI’s Axxia Networking Business and related assets for $650 million in cash. Adding the Axxia Networking Business capabilities to Intel’s portfolio will help accelerate the company’s strategy to become a leader in platform solutions for the network infrastructure. By providing a comprehensive product portfolio, Intel aims to help operators create a more efficient, scalable and flexible network to keep up with future bandwidth demands while also allowing for fast provisioning of new services. Read more in The Data Stack.

SAN JOSE, Calif., SINGAPORE and SANTA CLARA, Calif., August 13, 2014 – Avago Technologies Limited and Intel Corporation today announced the signing of a definitive agreement for Intel to acquire LSI's Axxia Networking Business and related assets for $650 million in cash.

 

The transaction, which has been approved by the boards of directors for both Avago and Intel, is expected to close in the fourth calendar quarter of 2014 upon satisfaction of government approvals and customary closing conditions.

 

LSI's Axxia Networking Business is being divested from Avago following the recent completion of Avago's acquisition of LSI. The Axxia Networking Business generated revenues of $113 million in calendar 2013 and employs approximately 650 people.

 

About Avago Technologies
Avago Technologies Limited is a leading designer, developer and global supplier of a broad range of analog semiconductor devices with a focus on III-V based products and complex digital and mixed signal CMOS based devices. Avago's product portfolio is extensive and includes thousands of products in four primary target markets: enterprise storage, wired infrastructure, wireless communications and industrial & other. For more information, visit Avago's website: www.avagotech.com.

 

About Intel
Intel (NASDAQ: INTC) is a world leader in computing innovation. The company designs and builds the essential technologies that serve as the foundation for the world's computing devices. As a leader in corporate responsibility and sustainability, Intel also manufactures the world's first commercially available "conflict-free" microprocessors. Additional information about Intel is available at newsroom.intel.com and blogs.intel.com and about Intel's conflict-free efforts at conflictfree.intel.com.

 

Intel and the Intel logo are trademarks of Intel Corporation in the United States and other countries.

 

*Other names and brands may be claimed as the property of others.

  • Big data analytics and data from wearable computing offer potential to improve monitoring and treatment of Parkinson's disease.
  • The Intel-built big data analytics platform combines hardware and software technologies to provide researchers with a way to more accurately measure progression of disease symptoms.

 

 

Big_Data_Analytics_Platform.jpg

Data is collected from Parkinson's patients via wearable devices, and housed in an open platform for analysis that may lead to new insights and improvements in care via a new partnership between Intel and the Michael J. Fox Foundation.

Patient_Analytics_with_Intel_Big_Data.jpg

Anonymous patient data is aggregated and analyzed for new insight into Parkinson's disease via a new partnership between Intel and the Michael J. Fox Foundation.

NEW YORK and SANTA CLARA, Calif. (Aug. 13, 2014) — The Michael J. Fox Foundation for Parkinson's Research (MJFF) and Intel Corporation announced today a collaboration aimed at improving research and treatment for Parkinson's disease — a neurodegenerative brain disease second only to Alzheimer's in worldwide prevalence. The collaboration includes a multiphase research study using a new big data analytics platform that detects patterns in participant data collected from wearable technologies used to monitor symptoms. This effort is an important step in enabling researchers and physicians to measure progression of the disease and to speed progress toward breakthroughs in drug development.

 

"Nearly 200 years after Parkinson's disease was first described by Dr. James Parkinson in 1817, we are still subjectively measuring Parkinson's disease largely the same way doctors did then," said Todd Sherer, PhD, CEO of The Michael J. Fox Foundation. "Data science and wearable computing hold the potential to transform our ability to capture and objectively measure patients' actual experience of disease, with unprecedented implications for Parkinson's drug development, diagnosis and treatment."

 

"The variability in Parkinson's symptoms creates unique challenges in monitoring progression of the disease," said Diane Bryant, senior vice president and general manager of Intel's Data Center Group. "Emerging technologies can not only create a new paradigm for measurement of Parkinson's, but as more data is made available to the medical community, it may also point to currently unidentified features of the disease that could lead to new areas of research."

 

Tracking an Invisible Enemy
For nearly two decades, researchers have been refining advanced genomics and proteomics techniques to create increasingly sophisticated cellular profiles of Parkinson's disease pathology. Advances in data collection and analysis now provide the opportunity to expand the value of this wealth of molecular data by correlating it with objective clinical characterization of the disease for use in drug development.

 

The potential to collect and analyze data from thousands of individuals on measurable features of Parkinson's, such as slowness of movement, tremor and sleep quality, could enable researchers to assemble a better picture of the clinical progression of Parkinson's and track its relationship to molecular changes. Wearables can unobtrusively gather and transmit objective, experiential data in real time, 24 hours a day, seven days a week. With this approach, researchers could go from looking at a very small number of data points and burdensome pencil-and-paper patient diaries collected sporadically to analyzing hundreds of readings per second from thousands of patients and attaining a critical mass of data to detect patterns and make new discoveries.

 

MJFF and Intel initiated a study earlier this year to evaluate the usability and accuracy of wearable devices for tracking agreed physiological features from participants and using a big data analytics platform to collect and analyze the data. The participants (16 Parkinson's patients and nine control volunteers) wore the devices during two clinic visits and at home continuously over four days.

 

Bret Parker, 46, of New York, is living with Parkinson's and participated in the study. "I know that many doctors tell their patients to keep a log to track their Parkinson's," said Parker. "I am not a compliant patient on that front. I pay attention to my Parkinson's, but it's not everything I am all the time. The wearables did that monitoring for me in a way I didn't even notice, and the study allowed me to take an active role in the process for developing a cure."

 

Intel data scientists are now correlating the data collected to clinical observations and patient diaries to gauge the devices' accuracy, and are developing algorithms to measure symptoms and disease progression.

 

Later this year, Intel and MJFF plan to launch a new mobile application that enables patients to report their medication intake as well as how they are feeling. The effort is part of the next phase of the study to enable medical researchers to study the effects of medication on motor symptoms via changes detected in sensor data from wearable devices.

 

Collecting, Storing and Analyzing the Data
To analyze the volume of data, more than 300 observations per second from each patient, Intel developed a big data analytics platform that integrates a number of software components including Cloudera® CDH* — an open-source software platform that collects, stores, and manages data. The data platform is deployed on a cloud infrastructure optimized on Intel® architecture, allowing scientists to focus on research rather than the underlying computing technologies. The platform supports an analytics application developed by Intel to process and detect changes in the data in real time. By detecting anomalies and changes in sensor and other data, the platform can provide researchers with a way to measure the progression of the disease objectively.

 

In the near future, the platform could store other types of data such as patient, genome and clinical trial data. In addition, the platform could enable other advanced techniques such as machine learning and graph analytics to deliver more accurate predictive models that researchers could use to detect change in disease symptoms. These advances could provide unprecedented insights into the nature of Parkinson's disease, helping scientists measure the efficacy of new drugs and assisting physicians with prognostic decisions.

 

Shared Commitment to Open-Access Data
MJFF and Intel share a commitment to increasing the rate of progress made possible by open access to data. The organizations aim to share data with the greater Parkinson's community of physicians and researchers as well as invite them to submit their own de-identified patient and subject data for analysis. Teams may also choose to contribute de-identified patient data for inclusion in broader, population-scale studies.

 

The Foundation has previously made de-identified data and bio-samples from its sponsored studies available to qualified researchers, including from individuals with a Parkinson's-implicated mutation in their LRRK2 gene. MJFF has also opened access to resources from its landmark biomarker study the Parkinson's Progression Markers Initiative (PPMI) since it launched in 2010. Parkinson's scientists around the world have downloaded PPMI data more than 235,000 times to date.

 

 

 

Press Materials

 

 

About The Michael J. Fox Foundation for Parkinson's Research
As the world's largest nonprofit funder of Parkinson's research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson's disease and improved therapies for those living with the condition today. The Foundation pursues its goals through an aggressively funded, highly targeted research program coupled with active global engagement of scientists, Parkinson's patients, business leaders, clinical trial participants, donors and volunteers. In addition to funding more than $450 million in research to date, the Foundation has fundamentally altered the trajectory of progress toward a cure. Operating at the hub of worldwide Parkinson's research, the Foundation forges groundbreaking collaborations with industry leaders, academic scientists and government research funders; increases the flow of participants into Parkinson's disease clinical trials with its online tool, Fox Trial Finder; promotes Parkinson's awareness through high-profile advocacy, events and outreach; and coordinates the grassroots involvement of thousands of Team Fox members around the world.

 

For more information, visit us on the Web, Facebook, Twitter, LinkedIn and Pinterest.

 

About Intel
Intel (NASDAQ: INTC) is a world leader in computing innovation. The company designs and builds the essential technologies that serve as the foundation for the world's computing devices. As a leader in corporate responsibility and sustainability, Intel also manufactures the world's first commercially available "conflict-free" microprocessors. Additional information about Intel is available at newsroom.intel.com and blogs.intel.com and about Intel's conflict-free efforts at conflictfree.intel.com.

 

Intel and the Intel logo are trademarks of Intel Corporation in the United States and other countries.

 

*Other names and brands may be claimed as the property of others.

Today, Intel and the Michael J. Fox Foundation announced a collaboration aimed at improving research and treatment for Parkinson’s disease - a neurodegenerative brain disease second only to Alzheimer’s in worldwide prevalence. The collaboration includes a multiphase research study using a new big data analytics platform that detects patterns in participant data collected from wearable technologies used to monitor symptoms. This effort is an important step in enabling researchers and physicians to measure progression of the disease and to help speed breakthroughs in drug development. Learn more about the research and see the video.

WHEN:

Sept. 9-11, 2014

WHERE:

Moscone Center West, San Francisco

WHAT:
brian-krzanich_2.jpg

Intel CEO Brian Krzanich

At the 2014 Intel Developer Forum (IDF14), developers, makers and creators will gather to share ideas and hear about how Intel will help them create the technology that will change the world. This year's event is all about the technology developers in attendance: their opportunities, their creations and ideas, and the benefits of joining the millions of developers worldwide who participate in the Intel architecture ecosystem.

 

The conference's format has been revamped this year. IDF14 will have one keynote with Intel CEO Brian Krzanich and special guests followed by two days of large breakout sessions, called Mega Sessions, where Intel executives will focus on technology trends and innovations. In addition, attendees will participate in three days of technical sessions with industry and Intel experts, hands-on demos and one of Intel's largest Tech Showcases.

 

The strong lineup of speakers includes:

 

Day 1

 

Keynote: Intel Chief Executive Officer Brian Krzanich will share Intel's vision for the future and provide updates on advancements with Intel technologies

 

Mega Sessions:

  • Internet of Things with Doug Davis
  • The Next Revolution in Computing: Intel® Edison, Wearables and New Devices with Mike Bell
  • Taking on the Developer Challenge with Doug Fisher
  • 'Appy Hour with Hermann' with Hermann Eul

 

Day 2

Mega Sessions:

  • The Data Center Opportunity with Diane Bryant
  • PC Reinvention and Innovation - Focus Areas for Developers with Kirk Skaugen

 

Exhibition: More than 180 leading companies from around the world will have hands-on demonstrations of their newest innovations and future technologies at the IDF Industry Technology Showcase.

 

Networking: IDF offers media and analysts opportunities to speak one-to-one with industry experts and Intel engineers whose work will impact the direction of future technologies. Poster Chats, Deep Dive Technical Insights, lecture sessions, hands-on labs and many other opportunities allow time for technical questions to be answered in an informal setting.

ATTENDANCE:

More than 4,500 attendees are expected from around the world.

 

View the Multimedia Press Kit
(includes the full story with high resolution photos, videos, quotes, fact sheets, and more)

 

CONTACTS:

Kathy Gill, Intel

503-696-6151, kathryn.m.gill@intel.com

Intel researchers, together with scientists at the Technical University of Munich and Ludwig Maximilian University of Munich, have been chosen as finalists for the prestigious 2014 Gordon Bell Prize. The annual award recognizes outstanding achievement in high performance computing (HPC) with a particular emphasis on rewarding innovation in applying HPC to applications in science, engineering and large-scale data analytics. Intel and its partners were selected for their work using supercomputers, powered by both Intel® Xeon® processors and Intel® Xeon Phi™ coprocessors, to create high-resolution and high-order realistic 3D seismic simulations. Insights gathered from these simulations will help societies better prepare for natural disasters such as earthquakes. This year’s winner will be announced at the SC14 awards ceremony this November in New Orleans. For more information on the nominated research project, read the Intel blog.

Broadwell_Package_Diagonal1.jpg

14nm Package (codenamed 'Broadwell')

SANTA CLARA, Calif., Aug. 11, 2014 – Intel today disclosed details of its newest microarchitecture that is optimized with Intel's industry-leading 14nm manufacturing process. Together these technologies will provide high-performance and low-power capabilities to serve a broad array of computing needs and products from the infrastructure of cloud computing and the Internet of Things to personal and mobile computing.

 

Key Points:

 

  • Intel disclosed details of the microarchitecture of the Intel® Core™ M processor, the first product to be manufactured using 14nm.
  • The combination of the new microarchitecture and manufacturing process will usher in a wave of innovation in new form factors, experiences and systems that are thinner and run silent and cool.
  • Intel architects and chip designers have achieved greater than two times reduction in the thermal design point when compared to a previous generation of processor while providing similar performance and improved battery life.
  • The new microarchitecture was optimized to take advantage of the new capabilities of the 14nm manufacturing process.
  • Intel has delivered the world's first 14nm technology in volume production. It uses second-generation Tri-gate (FinFET) transistors with industry-leading performance, power, density and cost per transistor.
  • Intel's 14nm technology will be used to manufacture a wide range of high-performance to low-power products including servers, personal computing devices and Internet of Things.
  • The first systems based on the Intel® Core™ M processor will be on shelves for the holiday selling season followed by broader OEM availability in the first half of 2015.
  • Additional products based on the Broadwell microarchitecture and 14nm process technology will be introduced in the coming months.

 

"Intel's integrated model – the combination of our design expertise with the best manufacturing process – makes it possible to deliver better performance and lower power to our customers and to consumers," said Rani Borkar, Intel vice president and general manager of product development. "This new microarchitecture is more than a remarkable technical achievement. It is a demonstration of the importance of our outside-in design philosophy that matches our design to customer requirements."

 

"Intel's 14 nanometer technology uses second-generation Tri-gate transistors to deliver industry-leading performance, power, density and cost per transistor," said Mark Bohr, Intel senior fellow, Technology and Manufacturing Group, and director, Process Architecture and Integration. "Intel's investments and commitment to Moore's law is at the heart of what our teams have been able to accomplish with this new process."

 

View the Multimedia Press Kit
(includes the full story with high resolution photos, videos, quotes, fact sheets, and more)

About Intel
Intel (NASDAQ: INTC) is a world leader in computing innovation. The company designs and builds the essential technologies that serve as the foundation for the world's computing devices. As a leader in corporate responsibility and sustainability, Intel also manufactures the world's first commercially available "conflict-free" microprocessors. Additional information about Intel is available at newsroom.intel.com and blogs.intel.com and about Intel's conflict-free efforts at conflictfree.intel.com.

 

Intel, Intel Core and the Intel logo are trademarks of Intel Corporation in the United States and other countries.

 

*Other names and brands may be claimed as the property of others.

Global workplace transformation is leading to new requirements for client technology. In a recent audiocast Tom Garrison, Intel vice president in the PC Client Group and general manager of the Business Client Platforms Division, shared an update on Intel's business platforms (including Intel® vPro™ technology and Intel® Small Business Advantage). In addition, Garrison explained how the company's business portfolio is strongly positioned to support new workplace environments by continuing to innovate on a foundation of security, manageability, stability and performance for the next generation business client user experience. Garrison also shared new data regarding enterprise PC refresh cycles. To listen to the audiocast recording, register online to then access the Intel BCPD Update.

An unknown individual has sent what purports to be a news release to some members of the media concerning Intel’s operations in Israel. This is a hoax.  The purported news release does not come from Intel and is false.

Industry analyst Jack Gold published a research note titled, “Replacing Enterprise PCs: The Fallacy of the 3-4 Year Replacement Cycle” which recommends enterprises adopt a much more frequent update of their PC fleet. “Enterprises should establish a PC refresh program that is not based on ’old thinking’ industry practices established many years ago,” says Jack Gold, president of J.Gold Associates, LLC. “We strongly recommend companies immediately move to a refresh cycle of two years for their corporate PCs. The increased levels of productivity available from newer devices offer both a substantial ROI of 500-1000 percent as well as provide for a more efficient workforce, allowing organizations to do more with the resources they currently have.” The report from Jack Gold notes that the cost of a new machine is considerably less today, on a device to employee expense ratio, than it was a decade ago when many of the recommendations were established. Organizations must look at the negative cost implications of keeping older devices past their prime.

Today, in Washington, D.C., Intel announced a new collaboration with USAID called the Women and the Web Alliance to catalyze an ecosystem of partners to address the gender and Internet gap by bringing more than 600,000 young women online in Nigeria and Kenya in the next three years. The Alliance consists of USAID, Intel, NetHope, World Pulse, World Vision, UN Women, and Women in Technology in Nigeria. To learn more visit the blog post.

As wearable technology takes off, the best experiences will be those that deliver the ideal combination of fit, style and function. Intel is announcing today Intel® IQ Software Kits, a set of software and features that will enable a number of different functions on wearable devices developed using Intel technology. These software kits are designed to help fashion, sports and lifestyle companies incorporate advanced functionality into their wearable designs, help speed time-to market, and ultimately provide people with a product experience that offers greater utility and value. Visit this blog post for more details.

Croma, one of India’s largest consumer electronics retail chains, announced its branded tablet and 2 in 1 based on Intel Atom Z3735 processor (Bay Trail), running Microsoft Windows 8.1. The new tablet and 2 in 1 offer amazing features, graphics, great performance with long battery life, all packed into a sleek form factor. The new devices will be available through Croma’s 101 outlets in 16 cities across the country and Cromaretail.com.

Note to Editors: Materials and multimedia available at: http://www.intel.com/newsroom/ifa

 

WHAT:

At IFA 2014, Intel will reveal new products and plans to usher in a new era of computing devices with its latest technology. Below is an overview of Intel's presenceat the show and planned press activities.

WHEN:

Intel press activities at IFA; Sept. 3 - 5, 2014

 

Intel Exhibition at IFA; Sept. 5 - 10, 2014

WHERE:

IFA Exhibition Ground, Berlin, Germany

 

Intel Booth: Hall 16

DETAILS:

Intel Keynote

kirk-skaugen_1a.jpg

 

Sept. 5, 5:00 p.m. - 6:00 p.m. CEST

CityCube Berlin; Messedamm 26, 14055 Berlin

 

IFA will feature a keynote presentation by Kirk Skaugen, senior vice president and general manager of personal computing at Intel Corporation. Skaugen will reveal new products and Intel's plans to usher in a new era of computing devices with its latest technology. Executive remarks will begin promptly at 5:00 p.m.

 

To secure your seat, please RSVP here

 

The keynote will be live-streamed in our online newsroom, and a replay will also be available.

 

 

Intel @ Showstoppers

Sept. 4, 6:00 p.m. – 9:00 p.m. CEST

IFA Exhibition Ground Hall 15.2; Berlin

 

Intel will showcase new Intel-based devices, Intel® RealSense™ technology and more at ShowStoppers @ IFA 2014, the Official Press Event of IFA.

 

To secure your seat, please RSVP here

 

 

Intel Bloghütte (Blogger Lounge)

Sept. 5 – Sept. 10 2014, 9:00 a.m. – 6:00 p.m. CEST

IFA Fairground, Intel Booth, Hall 16; Berlin

 

In the second floor of the Intel hall the Intel Bloghütte (Blogger Lounge) is waiting for you with an area to relax, super fast internet access and catering. Furthermore you find a working area equipped with the latest Intel-powered 2 in 1 devices.

 

To secure your seat, please RSVP here

Intel is a trademark of Intel Corporation in the United States and other countries.

 

* Other names and brands may be claimed as the property of others.

Intel® Business App Portfolio is now available for select tablets based on Intel® processors and Android. Intel has bundled a collection of top business apps that include Evernote, ooVoo, Dropbox, McAfee, DocuSign and others, to turn tablets into enhanced productivity tools for workers. With the app bundle, an employee can easily create and share documents and presentations; video conference; access company files in the cloud or a remote PC; guard sensitive data from viruses; and capture images and signatures for business contracts. At an estimated value over $250, the portfolio is a cost-effective solution that meets the needs and budgets of small businesses worldwide to accelerate achieving goals of improving customer interactions and sales growth. The app bundle is available for free by purchasing a qualifying tablet from Intel® Technology Partner members in North America, Latin America and Europe or through Amazon.com (in the U.S. and Canada).

Filter News Archive

By author:
By date:
By tag: